NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

Most people with type 2 diabetes should be offered SGLT-2 inhibitors much earlier in their treatment, final NICE guidance has ...

People diagnosed with type 2 diabetes before age 40 face a higher lifetime risk of heart and kidney problems, so may benefit from adding another type of medicine called a GLP-1 receptor agonist (such ...

Statistics indicate that type 2 diabetes (T2D) affects approximately 14% of the global population. This is significant because T2D is linked to various complications, including vision loss, kidney ...

Dietary advice and structured lifestyle interventions remain central to the effective management of Type 2 diabetes, with clinical guidelines emphasising the need for individualised, ...

Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification. Objectives: To describe ...

Nutritional interventions, particularly supplements, are associated with significant improvements in anxiety among patients with T2D.

Metformin is particularly effective for people with diabetes or prediabetes who have obesity and have difficulty managing their blood sugar through lifestyle changes alone. Metformin is a widely used ...